Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by I Berard
Time to Reimbursement for Oncology Drugs in EU5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Reimbursement Decisions in Oncology Drugs: An International Analysis
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Php217 - Time to Market and Price Comparison for Biosimilar Drugs in Eu5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pcn235 - Combination Oncology Therapies in the Eu5: Navigating the Road to Reimbursement and Optimizing Uptake in Malignant Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Pnd92 - Access and Reimbursement for Current and Emerging Alzheimer’s Disease-Modifying Therapies in the Eu5
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Reimbursement Approval of Oncology Drugs in Canada Supported by a Data Package Lacking Phase III Trial Data
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
New Reimbursement Schemes for Stratified Medicine in Oncology – A Systematic Review
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy137 - Orphan Drug Access and Reimbursement in the Eu5: Cystic Fibrosis and Duchenne Muscular Dystrophy
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
The Need for Transparency and Efficiency in Reimbursement Decisions Relating to Drugs for Rare Diseases
Medical Decision Making
Health Policy
Pmd168 - Market Access for Companion Diagnostics in Oncology in the Eu5 and Asia-Pacific Region
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
